Vascular Lesion Clinical Trial
Official title:
Oxygenation in Vascular Lesions of the Colon
The goal of this clinical trial is to evaluate oxygenation in the colon in people with acquired vascular abnormalities in the proximal colon.
| Status | Recruiting |
| Enrollment | 30 |
| Est. completion date | February 1, 2029 |
| Est. primary completion date | February 1, 2027 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 18 Years to 89 Years |
| Eligibility | Inclusion Criteria: - Undergo standard of care colonoscopy - People with a history of vascular lesions of the colon - People with healthy colon - 18 - 89 years of age Exclusion Criteria: - Age < 18 years - Age > 90 years - People with ulcerations in at ascending colon opposite the ileocecal valve - Previous colon surgery |
| Country | Name | City | State |
|---|---|---|---|
| United States | University of Chicago | Chicago | Illinois |
| Lead Sponsor | Collaborator |
|---|---|
| University of Chicago |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Quantitative analysis of colonic oxygen saturation levels | Colonic oxygen saturation levels will be compared between patients with vascular lesions of the colon and healthy controls. | baseline-12 months |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05630690 -
Evaluation of Safety and Efficacy of IPL Presets for Cutaneous Lesions
|
N/A | |
| Recruiting |
NCT01106937 -
Factor XIII and Pulmonary Embolism in Neurosurgical Patients
|
N/A | |
| Completed |
NCT04993066 -
Clinical Evaluation to Assess the Safety and Efficacy of GentleMax Pro Plus
|
N/A | |
| Recruiting |
NCT05674149 -
Image Data Collection Using a Multi-spectral Camera for Computer Vision Algorithms Research and Development
|
N/A | |
| Completed |
NCT05755139 -
Safety and Efficacy Evaluation of SMART Camera Treatment Presets for Cutaneous Lesions Using IPL
|
N/A | |
| Completed |
NCT00585338 -
Treatment of Vascular Lesions With a Tandem 532/1064 nm Laser
|
Phase 1 |